The Effects of 12-Week Prebiotic Supplementation on General Wellness and Exercise-Induced Gastrointestinal Symptoms in Recreationally Trained Endurance Athletes: A Triple-Blind Randomised Controlled Pilot Trial
<b>Background/Objectives</b>: Ingestion of galactooligosaccharides (GOSs) or GOS mixtures has been purported to improve exercise-induced gastrointestinal (GI) distress and post-exercise recovery. However, the effects have not been explored in recreationally trained endurance athletes. This triple-blind randomised controlled trial, therefore, investigated whether 12 weeks of B-GOS<sup>®</sup> supplementation affects gastrointestinal comfort and psychological wellbeing in recreational athletes. <b>Methods</b>: Eighteen physically active individuals (12 males, 8 females, 44 ± 14 years, 1.7 ± 0.1 m and 73 ± 14 kg) volunteered for this study. Participants were assigned to independent groups in a placebo-controlled, triple-blind manner via stratified randomisation. A 20 min run at 80% VO<sub>2max</sub> was completed, with measures for GI distress and Competitive State Anxiety Inventory-2 questionnaire (CSAI-2) pre- and post-exercise. A 12-week supplementation period then ensued, where participants ingested either 3.65 g of B-GOS or an appearance-matched maltodextrin placebo. During this time, physical activity levels (IPAQ-7), general stress (REST-Q), mental wellbeing (WEMWBS), and sleep (core consensus sleep diary) were measured at regular time points. <b>Results</b>: There were no significant differences in VO<sub>2max</sub> (<i>p</i> = 0.437), GI discomfort (<i>p</i> = 0.227), or CSAI-2 (<i>p</i> = 0.739-0.954) from pre- to post-exercise at any time point or between conditions. Over the 12 weeks there were no significant differences between B-GOS and placebo in IPAQ-7 (<i>p</i> = 0.144-0.723), REST-Q (<i>p</i> = 0.282-0.954), WEMWBS (B-GOS pre = 51 ± 10, post = 53 ± 7; PLA pre = 51 ± 4, post 54; <i>p</i> = 0.862), or sleep (<i>p</i> = 0.065-0.992). The linear mixed model suggests that some may benefit on an individual level in terms of WEMWBS, general stress score, recovery-related scores, sleep, and sport-specific recovery score. <b>Conclusions</b>: There were no group benefits of B-GOS supplementation compared with placebo, although the individual variation may warrant further research in larger sample sizes and longer-duration studies.
Authors
- Anthony Weldon (ORCID: https://orcid.org/0000-0001-5762-332X)
- Neil D. Clarke (ORCID: https://orcid.org/0000-0002-1909-329X)
- Lewis A. Gough (ORCID: https://orcid.org/0000-0003-1115-7559)
- Rachel Williams (ORCID: https://orcid.org/0000-0001-6353-944X)
- Charlie J. Roberts (ORCID: https://orcid.org/0000-0002-4683-4006)
- Cain C. T. Clark (ORCID: https://orcid.org/0000-0002-6610-4617)
- April M. Young (ORCID: https://orcid.org/0000-0003-3969-3249)
- Meghan Brown
Institutions
- Birmingham City University (GB)
- Leeds Beckett University (GB)
Publication Details
- Journal
- Nutrients
- Published
- 2025-10-28
- DOI
- https://doi.org/10.3390/nu17213390
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Birmingham City University